Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


June 30, 2015 8:42 PM ET

Biotechnology

Company Overview of Kosan Biosciences Incorporated

Key Executives for Kosan Biosciences Incorporated

NameBoard RelationshipsTitleAge
Peter J. Licari Ph.D.No RelationshipsSenior Vice President of Manufacturing & Operations50
Pamela S. Cohen M.D.No RelationshipsChief Medical Officer and Senior Vice President--
Pieter B.M.W.M. Timmermans Ph.D.No RelationshipsSenior Vice President of Drug Discovery & Preclinical Development64

Kosan Biosciences Incorporated Board Members*

NameBoard RelationshipsPrimary CompanyAge
Peter Davis Ph.D. 20 RelationshipsBionova Holding Corporation69
Christopher T. Walsh M.D., Ph.D. 116 RelationshipsREG Life Sciences, LLC70
Kevan E. Clemens Ph.D. 35 RelationshipsMEI Pharma, Inc.69
Bruce Allan Chabner M.D. 58 RelationshipsPeregrine Pharmaceuticals, Inc.73
Haruo Seto Ph.D. 14 RelationshipsKosan Biosciences Incorporated--
View All Board Members

Kosan Biosciences Incorporated Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Compensation Committee Ph.D.Peter Davis20 Relationships4 Executives
Nominating Committee M.D., Ph.D.Christopher T. Walsh116 Relationships2 Executives
Corporate Governance Committee M.D., Ph.D.Christopher T. Walsh116 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
361.7K
Bonus
222.0K
Total Short Term Compensation
445.1K
Total Value of Options
29.2M
Compensation as of Fiscal Year
Kosan Biosciences Incorporated CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Pee Cee Cosma Sope Ltd Announces Executive Changes
June 23, 2015 9:49 AM ET
Kimberly-Clark Elects Michael D. White to its Board of Directors
June 22, 2015 1:00 PM ET
Hipolin Announces Resignation of Nilesh Rajnikant Desai as Independent Director
June 10, 2015 10:30 AM ET
Frank A. Tataseo, Executive Vice President - New Business Development to Retire from the Clorox Company, Effective October 1, 2015
June 03, 2015 9:00 PM ET
Lokesh Sah Joins as Vice President on Reckitt Benckiser
June 03, 2015 10:30 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kosan Biosciences Incorporated, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.